Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Twist Bioscience Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 02:00PM GMT
Release Date Price: €37.2 (+6.29%)
Gregg Genova;UBS Securities Co. Ltd.;Managing Director
Healthcare Sector Sales Specialist,

Hey, good morning. Thank you, everyone, for attending the UBS Virtual Health Care Conference. This is Gregg Genova from the UBS equity sales team. The session is a fireside chat with Twist Biosciences. Happy to have here with me, Emily Leproust, Founder and CEO; and Jim Thorburn, CFO. So I have plenty of questions prepared. If you'd like to ask a question, please use the UBS conference website to input a question, and I'll be happy to ask Emily and Jim.

Questions & Answers

Gregg Genova;UBS Securities Co. Ltd.;Managing Director
Healthcare Sector Sales Specialist,

So with that, why don't I jump right in? So of course, front and center right now is COVID-19. I know you guys had some puts and takes. So let's first cover the positives. You had nearly, I think, $500,000 in revenue on the positive side from 3 main areas: the reference sequences, the enrichment panel, and of course, the custom

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot